Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLRX |
---|---|---|
09:32 ET | 4358 | 0.65 |
09:34 ET | 5400 | 0.6501 |
09:36 ET | 16499 | 0.65 |
09:50 ET | 5100 | 0.65 |
09:52 ET | 1000 | 0.650001 |
09:56 ET | 2540 | 0.65 |
09:59 ET | 599 | 0.6595 |
10:01 ET | 14742 | 0.6595 |
10:06 ET | 3000 | 0.666054 |
10:10 ET | 8000 | 0.666054 |
10:12 ET | 4279 | 0.659499 |
10:17 ET | 5803 | 0.659501 |
10:19 ET | 9103 | 0.65 |
10:33 ET | 1710 | 0.6501 |
10:37 ET | 3000 | 0.658465 |
10:42 ET | 600 | 0.66 |
10:48 ET | 100 | 0.6501 |
10:50 ET | 1743 | 0.6501 |
10:51 ET | 80674 | 0.65 |
10:53 ET | 300 | 0.655 |
10:57 ET | 50766 | 0.65 |
11:00 ET | 24060 | 0.65 |
11:02 ET | 400 | 0.6536 |
11:04 ET | 1300 | 0.6518 |
11:18 ET | 728 | 0.65 |
11:33 ET | 100 | 0.65 |
11:40 ET | 20512 | 0.650176 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioLine RX Ltd | 53.1M | -0.9x | --- |
Kronos Bio Inc | 57.3M | -0.6x | --- |
LAVA Therapeutics NV | 45.2M | -1.9x | --- |
Kezar Life Sciences Inc | 41.6M | -0.5x | --- |
Armata Pharmaceuticals Inc | 78.9M | -1.2x | --- |
Atara Biotherapeutics Inc | 55.0M | -0.2x | --- |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $53.1M |
---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.46 |
EPS | $-0.76 |
Book Value | $0.18 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.